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Gentamicin is a broad-spectrum antibiotic complex produced by actinomycetes belonging to 
Micromonospora genus and classified among aminoglycoside antibiotics, used in the treatment of serious 
infections derived from Gram-negative microorganisms. Alterations of their antimicrobial activity not 
shown in chemical assays can be evaluated through microbiological assays. The aim of this work was 
to compare 5 x 1, 2 x 2 and 3 x 1 experimental designs, evaluating validation parameters of specificity, 
linearity, range, precision, and accuracy for each experimental design in different levels of concentration, 
presentation, and lots. It consisted of 81 assays (in 3 replicas) of gentamicin microbiological dosage. The 
concentrations of the solutions used were employed in a range from 1.0 µg/mL to 5.0 µg/mL, diluted in 
phosphate buffer 0.1 M pH 8.0. Antibiotic medium number 11 was used, with Staphyloccocus epidermis 
(ATCC 12228). 21ml of medium were used as base layer and 4 ml of medium inoculated at 1% were 
used as surface layer. The dishes were incubated for 18 hours at 37 ± 1 oC. The three designs employed 
showed adequate specificity for analysis of dermatological cream and injectable solution containing 
gentamicin sulphate. They also showed accuracy and linearity in the range evaluated, but not a significant 
difference concerning precision. The results were compared by means of the determination of the rates of 
measurement system capacity. The statistical analysis demonstrated that there is no significant difference 
among the results obtained through 5 x 1, 2 x 2, and 3 x 1, being these equivalent and interchangeable.
Uniterms: Gentamicin/sulphate. Antibiotics/experimental design. Gentamicin/microbiological dosage. 
Antibiotics/qualitative analysis. Aminoglycoside antibiotics/antimicrobial activity.
A gentamicina é um complexo antibiótico de largo espectro, produzido por actinomicetos do gênero 
Micromonospora e classificado entre os antibióticos aminoglicosídeos, utilizado no tratamento de 
infecções graves, devidas a microrganismos Gram-negativos. Alterações da sua atividade antimicrobiana, 
não demonstradas pelos ensaios químicos, podem ser avaliadas pelos ensaios microbiológicos. O 
objetivo deste trabalho foi comparar os delineamentos experimentais 5 x 1, 2 x 2 e 3 x 1, avaliando-se 
os parâmetros de validação de especificidade, linearidade, faixa ou intervalo, precisão e exatidão para 
cada delineamento experimental em diferentes níveis de concentração, apresentações e lotes. O plano 
de trabalho constituiu-se na realização de 81 ensaios (em 3 réplicas) de doseamento microbiológico de 
gentamicina. As concentrações das soluções empregadas foram preparadas numa faixa de 1,0 mg/mL a 
5,0 mg/mL, diluídos em tampão fosfato 0,1 M pH 8,0. O meio utilizado foi o meio antibiótico no. 11, 
com Staphyloccocus epidermidis (ATCC 12228). Empregou-se 21 mL de meio como camada base e 4 
mL de meio inoculado à 1% como camada superfície. As placas foram incubadas por 18 horas à 37 ± 
1 °C. Os três delineamentos empregados apresentaram especificidade adequada para análise de creme 
dermatológico e solução injetável contendo sulfato de gentamicina. Também apresentaram exatidão e 
linearidade no intervalo avaliado. Os delineamentos não apresentaram diferença significativa quanto a 
precisão. Os resultados foram comparados através da determinação de índices de capacidade do sistema 
de medição. A analise estatística demonstrou que não há diferença significativa entre os resultados obtidos 
pelos delineamentos 5 x 1, 2 x 2 e 3 x 1, sendo equivalentes e intercambiáveis.
Uniterms: Gentamicina/sulfat. Antibióticos/delineamento experimental. Gentamicina/doseamento 
microbiológico. Antibióticos/análite qualitativa. Antibióticos aminoglicosídeos/atividade antimicrobiana.
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INTRODUCTION
The activity (potency) of antibiotics can be demons-
trated under adequate conditions through their inhibitory 
effect over microbial growth. A reduction in the antimi-
crobial activity can reveal subtle alterations that are not 
demonstrable through chemical methods (United States 
Pharmacopeia, 2006). Besides this, biological assays do 
not require specialized equipment or high toxicity solvents 
(Pinto et al., 2003b). The agar diffusion and turbidimetric 
are the two biological methods more commonly employed 
for antibiotic dosage.
The turbidimetric method depends on the growth 
inhibition of a microbial culture in an antibiotic uniform 
solution in fluid medium, which must be favorable to a 
quick microbial growth in the absence of antibiotic. This 
method takes into account the relation between the pro-
portion of growth of a microbial population in the liquid 
medium and the concentration of the assayed substance, 
being mostly used for vitamin and aminoacid dosage.
The agar diffusion method depends on the antibiotic 
diffusion through a layer of solidified agar, in an extension 
that totally inhibits the growth of the microorganism in 
an area or zone around the reservoir containing antibiotic 
solution. In this assay the size of the inhibition zone and 
the dose of the substance assayed are correlated. This is the 
most widely employed method to determine the potency 
of antibiotics. The diffusion method employs inoculated 
solid culture medium, distributed in dishes, in a system of 
mono or double layers, through which the test-substance 
spreads. The test-solution is applied on the surface of this 
medium in a restricted area, being the dishes then incuba-
ted: the microorganism growth occurs, respecting however 
the areas in which the antibiotic diffusion has occurred, 
generating contrast and resulting in the so-called growth 
inhibition zone. Such phenomenon originates all the theory 
that is the fundament of the diffusion method.
The official compendia and pharmacopoeias include 
antibiotic microbiological dosage assays. However, there 
is no consensus regarding the experimental designs. The 
balanced designs 3 x 3 and 2 x 2 are adopted by the Bra-
zilian (Farmacopéia Brasileira, 1988) and British (British 
Pharmacopoeia, 2004) pharmacopoeias, whereas the Ame-
rican (United States Pharmacopeia, 2006) pharmacopoeia 
presents 5 x 1 design for antibiotic dosage. The use of an 
adequate experimental design in relation to the criteria of 
linearity, precision, and accuracy of the analytical results is 
fundamental. It is highly advisable to adopt an experimental 
planning which, without further effort, supplies better re-
sults and enables an indication respecting the assay validity. 
The number and nature of the samples, as well as the results 
reliability level, are among the most important factors to be 
taken into account, in the selection of a design.
The 2 x 2 assay, known as symmetrical or balanced, 
is a simple and efficient design which employs two doses 
of the standard and two other of the sample, with identical 
ratio between the doses in both preparations. Each dish in-
cludes all the four doses, in such a way that the number of 
replicas equals that of dishes (Knudsen, 1945a; Knudsen 
1945b; Knudsen, Randall, 1945). The 5 x 1 assay, known 
as interpolation in standard curve assay, is a design with a 
standard curve of five concentrations. Each dish includes 
two doses, in alternate positions, being one of the concen-
trations in all the dishes a reference (central concentration 
of standard curve) and the other, one of the four standard 
concentrations, or the one corresponding to the sample 
dose with unknown potency (nominal dose equivalent to 
the standard reference) (Dart, 1966 United States Phar-
macopeia, 2006). Both designs present advantages and 
disadvantages. The validation of the analytical method 
is always fundamental to guarantee the quality of results. 
Linearity, accuracy and precision are some of the most 
important parameters for analytical method validation.
We can, therefore, observe that the determination 
of antimicrobial potency is extremely important for the 
control and quality assurance concerning pharmaceutical 
preparations, being thus necessary to develop practical 
and economical procedures which can be applied in the 
validation and dosage of drugs (Marques, 1988; Yama-
moto, 1994; 1996).
The association of the positive characteristics of 2 x 
2 and 5 x 1 designs would probably be of considerable inte-
rest, as it could improve validation parameters, generating 
safer and more reliable results. This fact not only makes 
the comparison between different types of designs justifia-
ble, as proposed by this project, but also the development 
of an alternative design which gathers all the necessary 
characteristics for safe and reliable analytical results.
The need for confirmation in terms of medicaments 
therapeutic efficacy is a concerning issue. There are situ-
ations in which the margin between the inefficient dose, 
under the therapeutic point of view, and a toxic dose is 
relatively small. Furthermore, even if the starting-point of 
the toxic dose is not reached, there is the economical aspect 
to be considered, as well as falsification with structurally 
similar molecules (Cooper, 1963; Pinto et al., 2003b).
Gentamicin, the first isolated antibiotic from the 
Micromonospora genera with therapeutic importance, has 
its potency microbiologically determined through the agar 
diffusion method (Oden, 1972; Campos, 1982), employing 
2 x 2 or 5 x 1 designs, according to Brazilian (Farmacopéia 
Brasileira, 1988) and American pharmacopoeias (United 
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States Pharmacopeia, 2006), respectively.
The association of 2 x 2 and 5 x 1 positive design 
characteristics would be considerably interesting, once it 
could improve the validation parameters, generating safer 
and more reliable results. The 3 x 1 design, proposed in this 
work, is an interpolation in the standard curve assay, which 
employs three doses of standard and one of sample, with 
nominal concentration equivalent to the standard median 
dose, including each dish all the preparations.
The aim of this work was to propose the use of 3 
x 1 experimental design for gentamicin microbiological 
dosage and to compare specificity, linearity, range, accu-
racy, and precision characteristics to those of 2 x 2 and 5 
x 1 experimental designs, commonly employed in genta-
micin microbiological dosage in different pharmaceutical 
preparations.
MATERIALS AND METHODS
Assay Method
Twenty seven samples of raw material were eva-
luated, as well as injectable solution and dermatological 
cream containing gentamicin sulphate. Each sample was 
assayed in 3 replicas using 2 x 2, 5 x 1, and 3 x 1 designs, 
in a total of 243 assays.
The standard solutions and samples were prepared 
using 0.1 M pH 8.0 phosphate buffer as diluent. The 
concentrations used for 2 x 2 design were 2.0 µg/mL (P1 
and A1) and 4.0 µg/mL (P2 and A2). For 5 x 1 design the 
concentrations were 1.3 µg/mL (P1), 1.6 µg/mL (P2), 
2.0 µg mL (P3), 2.5 µg/mL (P4), and 3.1 µg/mL (P5) for 
standard, and 2.0 µg/mL (A) for the sample. As for 3 x 
1 design the following concentrations were employed: 
1.0 µg/mL (P1), 2.0 µg/mL (P2), and 4.0 µg/mL (P3) for 
standard, and 2.0 µg/mL (A) for the sample. The dishes 
were prepared with 21 mL of antibiotic medium no 11. 
After the base layer solidification 4 ml of no11 antibiotic 
medium inoculated with Staphylococcus epidermidis 
(ATCC 12228) were added in a 1% proportion. Paper 
discs (Schleicher and Schuell®), with a diameter of 12.7 
mm, previously immersed in standard or sample solutions 
and having had the volume excess removed according to 
standards, were distributed in accordance with the expe-
rimental design employed.
The dishes were incubated in a Nova Ética (Mod. 
411 D) incubator for 18 hours at 37 ± 1 oC. After incubation 
the diameters of the inhibition halos were measured in 
millimeters with the help of an Eli Lilly Antibiotic Zone Re-
ader®. The results were then recorded and the calculations 
made according to the experimental design employed.
2 x 2 Design
In this assay, each dish includes all the doses, 
being the unknown low and high standard and sample 
potencies distributed in opposed positions. Figure 1 
indicates the disposition of paper discs (Schleicher and 
Schuell®) in each Petri dish. For each sample assayed 
by means of 2 x 2 experimental design, 6 dishes were 
employed.
The results obtained in this assay were calculated 
according to Hewitt (1977), as shown in the equations 
below. Each assay was evaluated through variance 
analysis (ANOVA) as to regression and parallelism, to 
guarantee the validity of the test.
Where: A1, A2, P1 and P2 are the means of 
diameters of the inhibition halos for low-dose sample 
solution, high-dose sample solution, low-dose standard 
solution and high-dose standard solution, respectively; 
M is the potency estimation and 2 is the dose ratio.
5 x 1 Design
In this assay, each dish contains two doses in alter-
nate position, being one of the concentrations in all the 
dishes a reference (central concentration of the standard 
curve), while the other, one of the standard four con-
centrations or the dose of the unknown potency sample 
(nominal dose equivalent to standard reference). Figure 
2 indicates the disposition of the paper discs (Schleicher 
and Schuell®) on each Petri dish. Sixteen dishes were 
employed in the standard curve and four in each sample 
assayed by means of experimental design 5 x 1.
After the correction of the curve points, the re-
sults of the 5 x 1 assays were calculated according to 
Hewitt (1977), as shown in the equations below. For 
FIGURE 1- Disposition of paper discs in each Petri plate for 
2x2 design.
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the purpose of assay validation, each standard curve 
was evaluated, through variance analysis, as to linearity 
and regression.
Where: P1, P2, P3, P4 and P5 are the means of 
diameters of the inhibition halos for standards solutions; 
A is the mean of diameters of inhibition halos for sample 
solution; M is the potency estimation and 1.25 is the 
dose ratio.
3 x 1 Design
In this assay, each dish includes all the doses, 
having the median standard dose and the dose of the 
unknown potency sample been distributed in opposed 
positions. Figure 3 indicates the disposition of the paper 
discs (Schleicher and Schuell®) on each Petri dish. Six 
dishes were employed for each sample assayed through 
3 x 1 experimental design (Lourenço, Pinto, 2007a; 
Lourenço, Pinto, 2007b; Pinto et al., 2007).
The results of these assays were calculated as sho-
wn in the equations above. Each assay was evaluated, 
through variance analysis, as to linearity and regression 
in order to guarantee the test validity.
Where: A, P1, P2 and P3 are the means of diame-
ters of the inhibition halos for sample solution, low-
dose standard solution, median-dose standard solution 
and high-dose standard solution, respectively; M is the 
potency estimation and 2 is the dose ratio.
Method Validation
The experimental designs employed in gentamicin 
microbiological dosage were evaluated as to specificity, 
accuracy, precision, linearity, and range (ICH, 1996; Bra-
sil, 2002; Inmetro, 2003; Pinto el al., 2003a).
Specificity was evaluated by means of the compari-
son of the diameters of the haloes obtained from gentami-
cin solution and gentamicin solution with the excipients 
of the dosage form evaluated. The haloes diameters were 
compared as to dispersion, using F-Snedecor test, and 
position, using t-Student test (Inmetro, 2003; Beiguelman, 
2002; Calleguri-Jacques, 2003).
FIGURE 3 - Disposition of paper discs in each Petri plate for 
3x1 design.
FIGURE 2 - Disposition of paper discs in each Petri plate for 5x1 design.
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Accuracy was evaluated in relation to fixed tendency 
and relative tendency and was determined through linear 
regression analysis, by plotting theoretical concentrations 
versus experimentally determined concentrations. The 
straight line equation, concerning the accuracy of each 
experimental design, was estimated through 81 experi-
mental determinations in three levels of concentration 
(70%, 100%, and 130% of the reference dose) in raw 
material, injectable solution and dermatological cream. 
It has been concluded that the methods are accurate, that 
is, they do not present fixed or relative tendency when the 
reliability intervals for linear and angular coefficients in-
clude, respectively, values 0 and 1 (Caulcutt, Boddy, 1982; 
Beiguelman, 2002; Calleguri-Jacques, 2003).
Precision was evaluated through the standard devia-
tion determined from 81 experimental determinations in 
three concentration levels (70%, 100%, and 130% of the 
reference dose) in raw material, injectable solution, and 
dermatological cream. The designs were compared as to 
precision through Bartlett and Levene tests. It was also 
evaluated if precision is associated with concentration 
through linear regression analysis, by plotting relative 
standard deviation versus concentration. This resulted in 
the verification that precision is not associated to concen-
tration when the angular coefficient reliability interval 
includes value 0 (Caulcutt, Boddy, 1982; Beiguelman, 
2002; Calleguri-Jacques, 2003).
Linearity was evaluated through linear regression 
analysis by correlation coefficient and the regression sig-
nificance. It was verified that the methods present linearity 
when the correlation coefficient (r) is bigger or equal to 
0.90 and the regression significance is inferior to 0.01 
(Caulcutt, Boddy, 1982; Beiguelman, 2002; Calleguri-
Jacques, 2003).
RE 899 resolution (Brasil, 2002), states that the 
recommended range for methodology of analytical quan-
titative determination in raw materials or dosage forms 
varies from 80% to 120% of the theoretical concentration. 
However, the specification for gentamicin, in the form 
of dermatological cream, described in USP 29 (United 
States Pharmacopeia, 2006), varies from 90% to 130% 
of the theoretical concentration. Thus the evaluation of 
the range was performed from 70% to 130% of the theo-
retical concentration. The interval was established by the 
confirmation that the method shows adequate accuracy, 
precision, and linearity.
Comparison of different designs
The comparisons of the designs were performed by 
determining the measurement system capacity rates (Mon-
tgomery, 2004). The latter were estimated by the ratio 
between the amplitude of the results under a determined 
condition and the linear range of the method employed 
(70% to 130% of the theoretical concentration). The rates 
evaluate the influence of the difference of the design in 
relation to the method application (Montgomery, 2004).
There is no significant influence of the type of design 
employed for values inferior to 10%, being the methods 
interchangeable. For values between 10% and 30% there 
is small influence, but still acceptable. When the values ex-
ceeded 30% the influence of the type of design employed 
was considered great, thus being impossible to ensure the 
methods interchange (Montgomery, 2004).
RESULTS AND DISCUSSION
The results of gentamicin microbiological dosage 
of raw material, injectable solutions and dermatological 
creams through 2 x 2, 5 x 1, and 3 x 1 designs are in Table I. 
The assays of 2 x 2 design were considered valid as 
to the regression significance (p <0.01) and parallelism 
(p >0.05). 5 x 1 design curves were considered valid as to 
linearity (r >0.90) and regression significance (p <0.01). 
The results obtained through 3 x 1 design were considered 
valid as to linearity (r >0.90) and regression significance 
(p <0.01).
In what concerns validation, 2 x 2, 5 x 1, and 3 x 
1 experimental designs presented specificity, accuracy, 
precision, linearity, and range adequate to the application 
of the methods.
The methods showed adequate specificity relatively 
to the injectable solution and the dermatological cream 
containing gentamicin sulphate.
Snedecor F tests demonstrated that there was no 
significant effect of the matrix as to the precision of the res-
ponses obtained. Student t tests demonstrated the absence 
of the matrix effect relatively to the injectable solution and 
the dermatological cream containing gentamicin sulphate. 
It has been thus guaranteed that the response obtained 
(inhibition halos diameter) is associated to the amount of 
gentamicin in the formulation.
The methods were considered accurate when the 
reliability intervals of linear and angular coefficients inclu-
de, respectively, values 1 and 0. None of the three designs 
showed fixed or absolute tendency and relative tendency, 
not being necessary to employ any kind of correction or 
adjustment of the results obtained.
The methods precision was quantified by the estima-
tion of the standard deviation of each design evaluated. The 
estimation of the standard deviation was determined by the 
square root of the variance analysis residual error for each 
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TABLE I - Results of 27 samples evaluated through 2 x 2, 5 x 1, and 3 x 1 designs
         
Level
2 x 2 Design
Raw Material Injectable solution Dermatological cream
Lot A Lot B Lot C Lot A Lot B Lot C Lot A Lot B Lot C
70%
67,7 62,6 70,0 64,2 64,5 64,9 70,5 80,5 69,5
74,3 68,4 62,9 63,3 76,6 63,4 84,8 78,5 73,9
73,4 68,2 68,2 62,7 71,3 69,6 78,3 74,1 69,6
100%
98,4 101,1 90,9 100,1 94,7 95,9 97,7 100,9 88,3
100,7 92,7 94,0 99,7 98,7 93,7 105,2 104,7 94,5
97,9 98,9 91,5 101,0 92,5 96,5 100,8 93,2 99,5
130%
136,9 123,6 121,3 129,3 125,1 128,2 143,9 137,3 125,4
129,0 132,0 133,0 122,3 129,0 128,2 162,0 135,1 122,4
134,3 123,2 131,3 138,6 139,3 129,4 130,3 128,0 128,8
Level
5 x 1 Design
Raw Material Injectable solution Dermatological cream
Lot A Lot B Lot C Lot A Lot B Lot C Lot A Lot B Lot C
70%
75,8 69,9 64,0 86,3 70,4 70,1 75,8 76,7 65,8
72,6 66,9 67,8 69,3 72,5 68,5 72,6 74,5 62,7
72,3 66,6 62,1 64,3 72,5 65,7 72,3 74,1 70,4
100%
96,8 96,9 89,9 108,4 103,8 94,0 96,8 101,6 93,2
96,2 94,1 97,2 96,1 102,9 99,2 96,2 98,4 83,2
96,2 100,9 89,9 97,5 102,5 100,3 96,2 100,9 95,4
130%
134,9 136,9 130,4 135,4 148,6 132,5 134,9 138,7 126,5
120,5 133,2 129,0 125,2 121,5 137,6 120,5 133,4 109,2
133,6 132,7 132,0 124,6 127,4 123,6 133,6 142,9 117,9
Level
3 x 1 Design
Raw Material Injectable solution Dermatological cream
Lot A Lot B Lot C Lot A Lot B Lot C Lot A Lot B Lot C
70%
64,1 58,8 66,0 78,3 75,0 68,6 79,6 71,6 56,9
68,1 69,2 69,3 62,2 64,6 68,9 66,8 60,3 70,9
64,0 72,9 71,3 65,7 63,7 71,2 75,1 62,9 61,7
100%
89,7 87,8 95,7 106,5 103,4 101,3 94,7 99,1 81,1
102,2 101,9 99,6 102,7 96,7 97,1 99,2 95,4 92,5
99,5 88,0 93,6 100,5 97,2 107,5 92,8 102,3 100,2
130%
128,3 113,1 127,8 120,8 129,6 138,1 144,8 124,5 123,5
143,2 125,8 127,5 143,8 125,0 132,6 141,7 134,2 119,3
115,5 142,9 132,6 123,6 125,1 132,6 126,3 139,9 127,1
Results expressed in %.
design. Bartlett and Levene tests indicated that there is no 
significant difference of precision in the designs evaluated. 
It has also been verified that precision is not associated to 
concentration when the angular coefficient reliability interval 
includes valueThe results demonstrated that there is linear 
association between the inhibition halos diameter and the 
logarithm of concentration, having in all the assays been 
obtained correlation coefficient above 0.90 and significant 
regression (p <0.01). The study showed adequate linearity, ac-
curacy and precision in the range of 1.0 µg/mL to 4.0 µg/mL.
Table II shows the measurement system capacity 
rates. It has been concluded that there is no significant 
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influence of the evaluated factor for values under 10%. 
When the latter range between 10% and 30% there is little 
influence, yet still acceptable. When values exceeded 30% 
the influence verified was great. The results demonstrated 
that the evaluated factors do not present significant in-
fluence on the methods application range (70% to 130% 
of the theoretical concentration). This implies that the 
differences found among the results obtained in different 
concentrations (designs, types of samples, concentration 
levels, and preparation lots) were not significant when 
compared to the methods application range.
The effect graphs (Figure 4) indicate the differences 
among the varied conditions evaluated relatively to the 
methods application range.
All the designs of the microbiological method pre-
sented adequate specificity in the analysis of injectable 
solution and dermatological cream containing gentamicin 
sulphate. The statistical tests demonstrated absence of 
matrix effect. 3 x 1 design showed adequate accuracy, not 
revealing fixed and relative tendencies in the evaluation of 
gentamicin sulphate raw material, injectable solution, and 
dermatological cream containing gentamicin, what was 
also verified in 2 x 2 and 5 x 1 designs. There is therefore 
no need to correct the results obtained by the methods 
studied. 3 x 1 design showed adequate precision in the 
evaluation of gentamicin sulphate raw material, injectable 
solution, and dermatological cream containing gentamicin, 
not presenting significant difference relatively to 2 x 2 and 
5 x 1 designs. The values of relative standard deviation for 
2 x 2, 5 x 1, and 3 x 1 designs were, respectively, 6.8%, 
7.1%, and 6.4%. The statistical evaluation showed that 
there is no association between the method precision and 
the concentration of gentamicin in the samples evaluated, 
what proves the homoscedasticity of the method, which 
presented significant regression and satisfactory linearity 
in the studied range of 1.0 µg/ml to 4.0µg/ml. The method 
application range was 70% to 130% of the theoretical 
concentration.
The designs studied were equivalent in the eva-
luation of gentamicin sulphate raw material, injectable 
solution, and dermatological cream containing gentamicin. 
The differences found among the results obtained in diffe-
rent conditions (designs, types of samples, concentration 
levels, and preparation lots) were insignificant when 
compared to the method application range.
The 2 x 2 assay is recommendable for research and 
development, as it supplies information about the regres-
sion significance and parallelism between the standard 
curve and the sample, what permits the evaluation of the 
test validity. The 5 x 1 assay proved to be appropriate for 
routine analysis in quality control laboratories, as it makes 
the simultaneous evaluation of a high number of samples 
possible. However, the necessity of correction makes cal-
culations complicated and more susceptible to mistakes. 
The 3 x 1 showed adequacy for routine analysis in quality 
control laboratories, as it simplifies the test execution and 
the potency calculation, besides offering advantages in 
terms of low cost and the material involved.
The proposed design can be applied to other antibio-
tics dosage. It is only necessary to evaluate the regression 
significance and the linearity of the curve employed.
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